Plain-English translation of NCT05813457 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a program called PRESTO designed to help people experiencing their first psychotic episode get specialized care more quickly. The program includes public education, training for doctors and staff who see patients first, and mobile teams who help connect patients to psychiatric specialists. The study will compare this new approach to usual care in France.
In France, people experiencing their first psychotic episode wait an average of 18 months or longer before receiving specialized treatment — much longer than in other countries. This delay can affect how well people recover. The new treatment aims to reduce this waiting time by raising awareness in the community and making it easier for primary care doctors to refer patients to specialists quickly.
You likely qualify if…
You likely don't qualify if…
If you are placed in the PRESTO program group, you will receive care that includes public awareness efforts about psychosis, coordinated training for doctors, and support from mobile teams who help you connect to psychiatric specialists. If you are in the usual care group, you will receive standard referral care. The study will track how quickly you access specialized care and measure the impact of the program on your treatment journey.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
France